Persons with narcolepsy with cataplexy have low levels of CSF hypocretin-1August 01, 2007WESTCHESTER, Ill. -- Persons with narcolepsy with cataplexy have low levels of cerebrospinal fluid (CSF) hypocretin-1, a protein thought to help regulate sleep and wakefulness, according to a study published in the August 1st issue of the journal SLEEP. The study, authored by Mona Skard Heier, MD, PhD, of Ullevål University Hospital in Oslo, Norway, focused on 64 previously diagnosed patients: 47 with narcolepsy with cataplexy, seven with narcolepsy without cataplexy and 10 with idiopathic central nervous system (CNS) hypersomnia, a condition characterized by recurrent daytime sleepiness without the abrupt sleep attacks classically seen in narcolepsy. The patients answered a questionnaire that asked about sleep habits, daytime sleepiness, accessory symptoms, duration and treatment. Low hypocretin-1 values were found in 72 percent of those patients with narcolepsy and cataplexy. Patients with low CSF hypocretin-1 levels reported more extensive muscular involvement during cataplectic attacks than patients with normal levels.
Patients with narcolepsy without cataplexy and idiopathic CNS hypersomnia all had normal hypocretin-1 levels. No significant clinical or biochemical differences were found between these patient groups. "Although hypnagogic hallucinations and sleep paralysis were most frequently reported by patients with narcolepsy with cataplexy than in the other patient groups, there was no correlation to low hypocretin-1 values," said Heier. "Hypnagogic hallucinations and sleep paralysis are usually thought to be isolated components of REM sleep in the waking state. Similarly, cataplexy has been considered as an isolated manifestation of REM sleep atonia, triggered by emotional stimuli." Narcolepsy is a sleep disorder that causes people to fall asleep uncontrollably during the day. It also includes features of dreaming that occur while awake. Other common symptoms include sleep paralysis, hallucinations and cataplexy. About one out of every 2,000 people is known to have narcolepsy. The chance that you have narcolepsy is higher when a relative also has it. It is very rare for more than two people in the same family to have this sleep disorder. It affects the same number of men and women. Those who suspect they might be suffering from narcolepsy, or another sleep disorder, are urged to consult with their primary care doctor or a sleep specialist. American Academy of Sleep Medicine | |||||||||||||||||||||
|
Related Narcolepsy Current Events and Narcolepsy News Articles PET imaging focuses on medication's purported ability to improve mental performance Concerned by the growing numbers of people using stimulant medications such as methylphenidate (MP)-either legally or illegally-to improve attention and focus, researchers used positron emission tomography (PET) imaging with the radiotracer fluorodeoxyglucose (FDG) to assess the effects of the drug on brain function in the normal human brain. JCSM: A single subjective question can be an effective sleepiness screening tool A single subjective (SS) question may be an effective screening tool for excessive daytime sleepiness, according to a study published in the April 15 issue of the Journal of Clinical Sleep Medicine (JCSM). New study in the journal SLEEP finds a high prevalence of eating disorders in narcoleptics The majority of patients with narcolepsy/cataplexy experience a number of symptoms of eating disorders, with an irresistible craving for food and binge eating as the most prominent features, according to a study published in the March 1 issue of the journal SLEEP. Journal SLEEP: Methylphenidate can have sleep benefits in adults with ADHD Treatment with methylphenidate (MPH) appears to have beneficial effects on sleep parameters in adults with ADHD, including increased sleep efficiency and a feeling of improved restorative value of sleep, according to a study published in the March 1 issue of the journal SLEEP. 2 different neural pathways regulate loss and regain of consciousness during general anesthesia University of Pennsylvania School of Medicine researchers have answered long-running questions about the way that anesthetics act on the body, by showing that the cellular pathway for emerging from anesthesia is different from the one that drugs take to put patients to sleep during operations. Practice parameters discuss treatment for narcolepsy, other hypersomnias of central origin Practice parameters published in the December 1 issue of the journal SLEEP serve as both an update of previous practice parameters for the therapy of narcolepsy and as the first practice parameters to address treatment of other hypersomnias of central origin, including idiopathic hypersomnia, recurrent hypersomnia and hypersomnia due to medical condition. Hormone links sleep, hunger and metabolism, researchers find While investigating how the hormone orexin might control sleep and hunger, researchers at UT Southwestern Medical Center have discovered, to their surprise, that it activates a protein, HIF-1, long known to stimulate cancerous tumor growth. Fish get insomnia, eyes wide open, say Stanford sleep researchers Scientists at the Stanford University School of Medicine have hooked a fish that suffers from insomnia in their quest to understand the genetics behind sleep disorders. Insomniac fish shed light on the molecular basis of sleep disorders Sleep disorders are common and poorly understood. In humans, narcolepsy is a sleep disorder associated with sleepiness, abnormal dreaming, paralysis and insomnia. Study: Modafinil is effective in treating excessive sleepiness A study published in the October 15 issue of the Journal of Clinical Sleep Medicine (JCSM) finds that modafinil is well-tolerated in the treatment of excessive sleepiness associated with disorders of sleep and wakefulness such as shift work sleep disorder, obstructive sleep apnea (OSA) and narcolepsy, and does not affect cardiovascular or sleep parameters. More Narcolepsy Current Events and Narcolepsy News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||